Anti-HER3 antibodies and compositions
US9217039B2 · kind B2 · utility
10Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2011 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Oct 31, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel therapeutic recombinant antibodies directed against HER3 (ErbB3), as well as compositions comprising mixtures of at least two of said recombinant anti-HER3 antibodies, and use of the antibodies and antibody compositions for treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.